XML 372 R162.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]      
Schedule of operating expenses

​

​

​

​

​

​

​

​

​

​

For the Three Months ended

​

​

September 30,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

​

$

3,361,858

​

$

1,248,189

General and administrative expenses

​

 

4,749,399

​

 

1,125,121

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

287,095

​

 

316,711

Total Operating Expenses

​

$

(8,398,352)

​

$

(2,690,021)

​

​

​

​

​

​

​

​

​

​

For the Nine Months ended

​

​

September 30,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

​

$

6,211,043

​

$

3,755,549

General and administrative expenses

​

 

11,569,376

​

 

3,546,510

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

665,832

​

 

1,015,118

Total Operating Expenses

​

$

(18,446,251)

​

$

(8,317,177)

 

​

​

​

​

​

​

​

​

​

​

For the year ended

​

​

December 31,

​

  ​ ​ ​

2024

  ​ ​ ​

2023

Research and development costs

​

$

5,176,932

​

$

7,152,913

General and administrative expenses

​

 

4,168,576

​

 

5,274,603

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

1,256,391

​

 

1,829,997

Total Operating Expenses

​

 

10,601,899

​

 

14,257,513

Revenue

​

 

248,357

​

 

18,614

Total other items

​

 

(1,110,903)

​

 

74,792

Income tax (expense) benefit

​

 

(20,965)

​

 

356,437

Net loss

​

$

(11,485,410)

​

$

(13,807,670)

HCM II Acquisition Corp      
Segment Reporting Information [Line Items]      
Schedule of operating expenses When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income and total assets, which include the following:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 

  ​ ​ ​

December 31, 

​

​

2025

​

2024

Marketable Securities held in trust account

​

$

242,642,972

​

$

235,193,585

Cash

​

$

350,389

​

$

668,089

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

​

​

  ​ ​ ​

For the 

​

​

​

​

​

​

​

​

​

Period 

​

​

​

​

​

​

​

​

​

from 

​

​

For the 

​

For the 

​

For the 

​

April 4, 

​

​

Three 

​

Three 

​

Nine

​

2024

​

​

Months 

​

Months 

​

Months 

​

(Inception) 

​

​

Ended 

​

Ended 

​

Ended 

​

Through 

​

​

September 30, 

​

September 30, 

​

September 30, 

​

September 30, 

​

​

2025

​

2024

​

2025

​

2025

Net income

​

$

1,927,839

​

$

1,071,221

​

$

3,218,865

​

$

1,018,558

General and administrative expenses

​

$

1,638,082

​

$

278,494

​

$

4,230,522

​

$

331,157

Interest earned on marketable securities held in Trust Account

​

$

2,508,797

​

$

1,349,715

​

$

7,449,387

​

$

1,349,715

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income and total assets, which include the following:

​

​

​

​

​

​

  ​ ​ ​

December 31,

​

​

2024

Trust Account

​

$

235,193,585

Cash

​

$

668,089

​

​

​

​

​

​

  ​ ​ ​

December 31,

​

​

2024

Net income (loss)

​

$

3,408,788

General and administrative expenses

​

$

634,797

Interest earned on marketable securities held in Trust Account

​

$

4,043,585